Scynexis Switches Focus To Hospital Indications For Ibrexafungerp

 
• By Joseph Haas
  
Scynexis focus
Scynexis believes hospital-based indications will be more lucrative for its antifungal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business